Document is current
Any future updates will be listed below
-
Authors
Vienne, Agathe
Collet, Laetitia
Chevalier, Thomas
Borel, Christian
Tardy, Magalie
Huguet, Florence
Richard, Sandrine
Salas, Sebastien
Saada-Bouzid, Esma
Fayette, Jerome
Daste, Amaury
- License Information
-
More Information
Article History
Received: 13 January 2023
Accepted: 29 June 2023
First Online: 14 July 2023
Declarations
:
: AD received Honoria from Astrazeneca, BMS, MSD, Merck, have consulting or advisory role for BMS, MSD, Merck. JF received honoraria from Astrazeneca, BMS, MSD, Merck, Innate Pharma, have consulting or advisory role for Astrazeneca, BMS, MSD, Merck, Innate Pharma, Roche, research funding from BMS and travel and accomodations from BMS, Astrazeneca, MSD, FH have consulting or advisory role for BMS, MSD, Merck and Amgen. CB has received honorariums for consulting by Merck, Astra-Zeneca, BMS, and has been Advisory board consultant for Merck and BMS. The others authors declared no conflict of interest.
: for the study was conducted according the CHU Bordeaux Ethics comittee. The study was conducted according to French National Statement on Ethical Conduct in Human Research (2007 and updates) and the World Medical Association Declaration of Helsinki (2013 and updates). Informed consent was waivered due to the retrospective nature of the study in accordance with CHU Bordeaux Ethics comittee.
: Not Applicable.
